Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest

Current Opinion in Critical Care

Volumn 7, Issue 3, 2001, Pages 176-183

  Böttiger, Bernd W ^a   Martin, Eike ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING; CORONARY ARTERY THROMBOSIS; FIBRIN FORMATION; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART ARREST; HEART MUSCLE REPERFUSION; HUMAN; LUNG EMBOLISM; RESUSCITATION; REVIEW; SURVIVAL; TREATMENT CONTRAINDICATION;

BLOOD COAGULATION; BRAIN; CARDIOPULMONARY RESUSCITATION; EMERGENCY MEDICAL SERVICES; HEART ARREST; HUMANS; REPERFUSION; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 0034971546     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200106000-00006     Document Type: Review

References (65)

1. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest
2. A randomized clinical study of a calcium entry blocker (lidoflazine) in the treatment of comatose survivers of cardiac arrest
3. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation
4. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation
5. Thrombolytic therapy in acute myocardial infarction: Selected recent developments
6. Die akute thrombembolie der lunge: Klinik, pathophysiologie, diagnostik, therapie
7. A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
8. Cause of death in unsuccessful prehospital resuscitation
9. Immediate coronary angiography in survivers of out-of-hospital cardiac arrest
10. Sudden cardiac death
11. Erfolgreiche behandlung einer fulminanten lungenembolie durch hochdosierte bolusinjektion von urokinase während der kardiopulmonalen reanimation
12. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism
13. High-dose bolus injection of urokinase: Use during cardiopulmonary resuscitation for massive pulmonary embolism
14. Thrombolysis during cardiopulmonary resuscitation
15. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial
16. Einsatzmöglichkeiten der thrombolyse in der reanimation
17. Präklinische ultima-ratio-thrombolyse bei therapierefraktärer kardiopulmonaler reanimation
18. Hochdosierte streptokinasetherapie bei fulminanter lungenarterienembolie
19. Cardac arrest and the role of thrombolytic agents
20. Thrombolyse bei reanimierten patienten mit lungenembolie
21. Thrombolyse unter reanimationsbedingungen
22. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: Outcome of a case series
23. Lysetherapie bei protrahierter kardio-pulmonaler reanimation: Nutzen und komplikationen
24. Effect of fibrinolytic activation on survival and cerebral demage following periods of circulatory arrest
25. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: An experimental study in the cat
26. The effect of combined Dextran and streptokinase on cerebral function and blood flow after cardiac arrest: An experimental study on the dog
27. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator
28. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy
29. Assessment of outcome after severe brain damage
30. Safety of thrombolysis in association with cardiopulmonary resuscitation
31. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction
32. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation
33. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation
34. Thrombolysis after resuscitation in acute myocardial infarction
35. Reperfusion therapy after pre-hospital cardiac arrest and its influence on outcome after acute myocardial infarction
36. Reversion of spontaneous circulation in patients with persistent ventricular fibrillation by treatment with recombinant tissue plasminogen activator
37. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis
38. Platelet factor 4 release in patients undergoing cardiopulmonary resuscitation: Can reperfusion be impaired by platelet activation?
39. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest
40. Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation
41. The mechanism ef death after resuscitation following acute circulatory failure
42. The use of protease inhibitor (Trasylol) and heparin in cardiorespiratory resuscitation I: Studies of the blood clotting system
43. Amelioration of brain damage after 12 minutes cardiac arrest in dogs
44. Cerebral ischemia II: The no-reflow phenomenon
45. Reassesment of cerebral capillary changes in acute global ischemia and their relationship to the "no-reflow" phenomenon
46. No-reflow after cardiac arrest
47. The topography of impaired microvascular perfusion in the primate brain following total circulatory arrest
48. Ischemia-mediated neuronal injury
49. Cerebral resuscitation after cardiac arrest: A review
50. Neuronal stress response and neuronal cell damage, following cardiocirculatory arrest in rats
51. Volume expansion during cardiopulmonary resuscitation reduces cerebral no-reflow
52. Research work on blood clotting system during cardiopulmonary resuscitation
53. Activation of Hageman factor by cardiac arrest
54. Cerebral blood flow dynamics in hypotension and cardiac arrest
55. Changes in cerebral microcirculation system following experimentally induced cardiac arrest: A SEM and TEM study
56. 2 during and after cardiopulmonary resuscitation
57. Intravascular platelet aggregation in the heart induced by norepinephrine
58. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin
59. Activation of Hageman factor by alpha-adrenergic stimulation
60. Intravascular changes in kidneys and lungs after external cardiac massage: A preliminary report
61. Survival from catastrophic intraoperative pulmonary embolism
62. Successful thrombolysis with rtPA after syncope and protracted cardiopulmonary resuscitation in massive pulmonary embolism
63. Successful thrombolysis of a fulminant lung embolism during cardiopulmonary resuscitation
64. Prehospital thrombolytic treatment of massive pulmonary embolism with reteplase during cardiopulmonary resuscitation
65. Successful resuscitation after bolus injection of tissue-type plasminogen activator in emergency admission